Women with a breast cancer responsive to estrogens often undergo adjuvant therapy to reduce circulating estrogen. This may be done with tamoxifen or an aromatase inhibitor. Serum levels of estradiol should be monitored in perimenopausal or postmenopausal women receiving estrogen suppression.
